Výsledky vyhledávání

Doporučená témata ve výsledcích tohoto hledání:
Upřesnit hledání
  1. 1
    Perspectives in the treatment of pancreatic adenocarcinoma

    Perspectives in the treatment of pancreatic adenocarcinoma Autor Ángel Cid-Arregui

    Vydáno 2015
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality

    Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality Autor Chiara De Divitiis

    Vydáno 2014
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*

    Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)* Autor David M. Goldenberg, Thomas M. Cardillo, Serengulam V. Govindan, Edmund A. Rossi, Robert M. Sharkey

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study

    Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study Autor Mitsukuni Suenaga, Nobuyuki Mizunuma, Satoshi Matsusaka, Eiji Shinozaki, Masato Ozaka, Mariko Ogura, Toshiharu Yamaguchi

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Oncolytic reovirus preferentially induces apoptosis in <i>KRAS</i> mutant colorectal cancer cells, and synergizes with irinotecan

    Oncolytic reovirus preferentially induces apoptosis in <i>KRAS</i> mutant colorectal cancer cells, and synergizes with irinotecan Autor Radhashree Maitra, Raviraja N. Seetharam, Lydia Tesfa, Titto Augustine, Lidija Klampfer, Matthew Coffey, John M. Mariadason, Sanjay Goel

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer

    Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer Autor Christopher R. Garrett, Tanios Bekaii‐Saab, Theresa Ryan, George A. Fisher, Sally Clive, Petr Kavan, Einat Shacham‐Shmueli, Aby Buchbinder, Richard M. Goldberg

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer

    Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer Autor Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas, Amer H. Zureikat, Barry C. Lembersky, Michael K. Gibson, Ronald G. Stoller, Herbert J. Zeh, Nathan Bahary

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation

    The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation Autor Jin Hu, Johan Kinn, A. Ali Zirakzadeh, Amir Sherif, Gunnar Norstedt, A-C Wikström, Ola Winqvist

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1

    Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1 Autor Barbara Jonchère, Alexandra Vétillard, Bertrand Toutain, David Lam, Anne Charlotte Bernard, Cécile Henry, Sophie de Carné Trécesson, Érick Gamelin, Philippe Juin, Catherine Guette, Olivier Coqueret

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous <scp>FOLFOX</scp> and bevacizumab for patients with unresectable colorectal liver‐limited metastasis

    Randomized controlled trial of irinotecan drug‐eluting beads with simultaneous <scp>FOLFOX</scp> and bevacizumab for patients with unresectable colorectal liver‐limited metastasis... Autor Robert C.G. Martin, Charles R. Scoggins, Marshall T. Schreeder, William S. Rilling, Christopher J. Laing, Clifton M. Tatum, Lawrence R. Kelly, Ricardo García‐Mónaco, Vivek R. Sharma, Todd S. Crocenzi, Steven M. Strasberg

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Cisplatin and 5‐fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis

    Cisplatin and 5‐fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis Autor Giuseppe Di Lorenzo, Carlo Buonerba, Piera Federico, Sisto Perdonà, Michele Aieta, Pasquale Rescigno, Carmine D’Aniello, Livio Puglia, Antonella Petremolo, Matteo Ferro, Alfredo Marinelli, Giovannella Palmieri, Guru Sonpavde, Vincenzo Mirone, Sabino De Placido

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Safety, pharmacokinetics, and activity of EZN‐2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies

    Safety, pharmacokinetics, and activity of EZN‐2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies Autor Razelle Kurzrock, Sanjay Goel, Jennifer J. Wheler, David S. Hong, Siqing Fu, Keyvan Rezaï, Sonia K. Morgan‐Linnell, Saı̈k Urien, Sridhar Mani, Imran Chaudhary, Mohammed H. Ghalib, Aby Buchbinder, François Lokiec, Mary F. Mulcahy

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

    Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after... Autor Gilles Freyer, P Rougier, R. Bugat, J‐P Droz, Marion Marty, Harry Bleiberg, D. Mignard, Lucile Awad, Patrice Herait, Stéphane Culine, V. Trillet-Lenoir

    Vydáno 2000
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Current status of pharmacological treatment of colorectal cancer

    Current status of pharmacological treatment of colorectal cancer Autor Reyhan Akhtar, Shammy Chandel, Pooja Sarotra, Bikash Medhi

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Targeted inhibition of <scp>IL</scp>‐18 attenuates irinotecan‐induced intestinal mucositis in mice

    Targeted inhibition of <scp>IL</scp>‐18 attenuates irinotecan‐induced intestinal mucositis in mice Autor Roberto César Pereira Lima‐Júnior, H. Freitas, Deysi Viviana Tenazoa Wong, Carlos W. Wanderley, Luiza Gabrielle Assunção Nunes, Leandro Linhares Leite, Samuel P. Miranda, Marcellus Henrique Loiola Ponte de Souza, Gerly Anne de Castro Brito, Pedro Jorge Caldas Magalhães, Mauro Martins Teixeira, Fernando Q. Cunha, Rita A. Ribeiro

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues

    Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologu... Autor Bertrand Brieau, Laëtitia Dahan, Yann De Rycke, Tarek Boussaha, Philippe Vasseur, David Tougeron, Thierry Lecomte, Romain Coriat, Jean‐Baptiste Bachet, Pierre Claudez, Aziz Zaanan, Pauline Soibinet, Jérôme Desramé, Anne Thirot‐Bidault, Isabelle Trouilloud, Florence Mary, Lysiane Marthey, Julien Taı̈eb, Wulfran Cacheux, Astrid Lièvre

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children

    Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children Autor Alberto Broniscer, Lisa Iacono, Murali Chintagumpala, Maryam Fouladi, Dana Wallace, Daniel C. Bowers, Clinton F. Stewart, Matthew J. Krasin, Amar Gajjar

    Vydáno 2004
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Perspectives on Biologically Active Camptothecin Derivatives

    Perspectives on Biologically Active Camptothecin Derivatives Autor Ying-Qian Liu, Wen-Qun Li, Susan L. Morris‐Natschke, Keduo Qian, Yang Liu, Gao-Xiang Zhu, Xiao-Bing Wu, An-Liang Chen, Shao-Yong Zhang, Xiang Nan, Kuo‐Hsiung Lee

    Vydáno 2015
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐based chemotherapy

    Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... Autor Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

    N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy Autor Jennifer A. Crozier, Pooja Advani, Betsy LaPlant, Timothy J. Hobday, Anthony J. Jaslowski, Alvaro Moreno‐Aspitia, Edith A. Perez

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: